Cardiovascular Health

September 10th 2025

Investigators emphasize that early cardiovascular risk assessments and preventative strategies are necessary for women with polycystic ovarian syndrome (PCOS).

September 8th 2025

The trial results, which showed baxdrostat significantly reduced mean seated systolic blood pressure in uncontrolled hypertension, were presented at the 2025 European Society of Cardiology Congress.

September 4th 2025

GLP-1 medications like semaglutide and tirzepatide significantly lower heart failure hospitalization risks, expanding treatment options for obesity-related conditions.

September 3rd 2025

Reduced-dose apixaban maintains efficacy with less bleeding for extended CAT prophylaxis, reinforcing NCCN’s preexisting guidance in intermediate to high-risk cancer patients.